JasonFontenotMD

Anesthesiology • Opelousas, LA

Physician

Join to view full profile

Dr. Fontenot is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Fontenot's full profile

Already have an account?

Office
539 E Prudhomme St
Opelousas, LA 70570
Phone+1 337-948-5120
Is this information wrong?

Education & Training

San Antonio Uniformed Services Health Education ConsortiumResidency, Anesthesiology, 1993 - 1996
William Beaumont Army Medical CenterResidency, Obstetrics and Gynecology, 1990 - 1992
LSU School of Medicine in ShreveportClass of 1990

Certifications & Licensure

LA State Medical License 1990 - 2025
TX State Medical License 1997 - 2024
NY State Medical License 2017 - 2022
NC State Medical License 2017 - 2022
PA State Medical License 1994 - 1994
American Board of Anesthesiology Anesthesiology

Publications & Presentations

PubMed

TH-F-211-02: Evaluation of a Proton Pencil Beam Alogirithm for Dose Calculations in Heterogeneous Media.
> ;Med Phys. 2012 Jul 05
SU-E-T-588: A Treatment Planning Comparison of Dual-Arc VMAT Vs. Helical Tomotherapy for Post-Mastectomy Radiotherapy.
> ;Med Phys. 2012 Jul 05
SU-E-T-535: Proton Dose Calculations in Homogeneous Media.
> ;Med Phys. 2012 Jul 05
Structure of a tumor associated antigen containing a tandemly repeated immunodominant epitope.
Fontenot JD, Mariappan SV, Catasti P, Domenech N, Finn OJ, Gupta G> ;J. Biomol. Struct. Dyn.. 1995-10-01
N-acetylgalactosamine glycosylation of MUC1 tandem repeat peptides by pancreatic tumor cell extracts.
Nishimori I, Perini F, Mountjoy KP, Sanderson SD, Johnson N, Cerny RL, Gross ML, Fontenot JD, Hollingsworth MA> ;Cancer Res.. 1994-07-15
Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients.
Kotera Y, Fontenot JD, Pecher G, Metzgar RS, Finn OJ> ;Cancer Res.. 1994-06-01
Structure and self assembly of a retrovirus (FeLV) proline rich neutralization domain.
Fontenot, J. D., Tjandra, N., Ho, C., Andrews, P. C., Montelaro, R. C.> ;J Biomol Struct Dyn. 1994 Feb
Biophysical characterization of one-, two-, and three-tandem repeats of human mucin (muc-1) protein core.
Fontenot, J. D., Tjandra, N., Bu, D., Ho, C., Montelaro, R. C., Finn, O. J.> ;Cancer Res. 1993 Nov 15
Synthesis of large multideterminant peptide immunogens using a poly-proline beta-turn helix motif.
Fontenot, J. D., Finn, O. J., Dales, N., Andrews, P. C., Montelaro, R. C.> ;Pept Res. 1993 Nov 01
Evaluation of feline immunodeficiency virus and feline leukemia virus transmembrane peptides for serological diagnosis.
Fontenot, J. D., Hoover, E. A., Elder, J. H., Montelaro, R. C.> ;J Clin Microbiol. 1992 Jul
A survey of potential problems and quality control in peptide synthesis by the fluorenylmethoxycarbonyl procedure.
Fontenot, J. D., Ball, J. M., Miller, M. A., David, C. M., Montelaro, R. C.> ;Pept Res. 1991 Jan 01
Managing orthodontic data on a small computer.
Weinberg, R., Fontenot, J., Ledoux, W. R., McInnes-Ledoux, P.> ;Angle Orthod. 1987 Jul
Join now to see all

Press Mentions

Sangamo Therapeutics Appoints Rob Schott, MD, MPH, FACC, as Head of Development; Elevates Jason Fontenot, PhD to Chief Scientific OfficerFebruary 1st, 2021
Inovio Adds Two to the Leadership Team; Adrian Woolfson Is Out at SangamoJune 26th, 2020
Chutes & Ladders—Allergan Ex-CEO Saunders Takes Board Seat at BridgeBioJune 26th, 2020

Hospital Affiliations

Opelousas General Health SystemOpelousas, Louisiana

JasonFontenotMD

Dr. Fontenot is on Doximity

Education & Training

Certifications & Licensure

Publications & Presentations

Press Mentions

Hospital Affiliations

Viewing the full profile is available to verified healthcare professionals only.